About Us
Meet Our Team
Our scientists, engineers, and project managers bring decades of combined expertise in molecular biology, synthetic biology, and biopharmaceutical R&D.
We are committed to scientific excellence, transparency, and collaborative partnership to help our clients achieve their goals faster.
Lipeng Wu, Ph.D.
Dr. Lipeng Wu is the Co-Founder and CEO of BioArk Technologies, a pioneering biotech company advancing gene editing solutions from research to real-world therapies. With over 20 years of experience in cancer biology, CRISPR engineering, and product development, Dr. Wu has built a career at the intersection of science and innovation. He holds a Ph.D. in Biochemistry and Molecular Biology from Peking University Health Science Center, where he earned national recognition for his work in epigenetic drug discovery. Passionate about transforming cutting-edge science into impactful healthcare solutions.
About BioArk Technologies
BioArk Technologies is a biotechnology and biopharmaceutical CRO specializing in gene editing and delivery. Using proprietary platforms, our team engineers DNA and RNA to support research across therapeutic areas such as immunology, oncology, and neuroscience. We offer comprehensive molecular services, viral packaging, and stable cell line development to help accelerate discoveries and advance genetic medicine.
